Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02723929 · ClinicalTrials.gov registry record
Effects of tDCS and tUS on Pain Perception in OA of the Knee
A clinical trial of Chronic Pain and Osteoarthritis, sponsored by Spaulding Rehabilitation Hospital.
- Active
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT02723929: Active study of Chronic Pain and Osteoarthritis, sponsored by Spaulding Rehabilitation Hospital.
NCT02723929 is a study of Chronic Pain and Osteoarthritis that is active but no longer recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 64 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02723929, a study of Chronic Pain and Osteoarthritis, is active but no longer recruiting, sponsored by Spaulding Rehabilitation Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) on pain perception and functional limitations in people with osteoarthritis of the knee. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.
Primary Outcome
Changes in the Visual Analogue Scale (VAS) for pain were measured in order to determine whether transcranial direct current stimulation in conjunction with transcranial ultrasound is effective in reducing pain in subjects with Osteoarthritis of the Knee. The VAS scale goes from 0 up to 10, where 0 means no pain at all and 10 means the worst imaginable pain and is reported following the full course of therapy. Since we are using a difference, smaller values (negative) represent a better outcome
Conditions Studied
Interventions
- DEVICE active low-intensity transcranial electrical stimulation/active transcranial ultrasound
- DEVICE Sham low-intensity transcranial electrical stimulation/sham transcranial ultrasound
Study Locations (1)
Massachusetts
- Spaulding Rehabilitation Network Research Institute - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-09 |
| Est. Completion | 2026-12-07 |
What the registry record for NCT02723929 still lists
NCT02723929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which active low-intensity transcranial electrical stimulation/active transcranial ultrasound is the first listed.
NCT02723929 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02723929 about?
NCT02723929 is a clinical study titled "Effects of tDCS and tUS on Pain Perception in OA of the Knee". The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) in conjunction with transcranial ultrasound (TUS) on pain perception and functional limitations in people with osteoarthritis of the knee. The investigators hypothesize that there will be a decr...
What is the current status of trial NCT02723929?
This trial is currently active not recruiting. The enrollment target is 64 participants. The study started on 2016-09. Estimated completion is 2026-12-07.
What conditions does trial NCT02723929 study?
This clinical trial studies the following conditions: Chronic Pain, Osteoarthritis.
What interventions are being tested in trial NCT02723929?
The interventions under investigation include: active low-intensity transcranial electrical stimulation/active transcranial ultrasound (DEVICE), Sham low-intensity transcranial electrical stimulation/sham transcranial ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02723929?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02723929 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02723929's enrollment target sits among peer trials
64 173rd of 301 higher than 128 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia